banner
You are not using a standards compliant browser. Because of this you may notice minor glitches in the rendering of this page. Please upgrade to a compliant browser for optimal viewing:
Firefox
Internet Explorer 7
Safari (Mac and PC)
View News Comments
Link Information - Click to View
Rate Story:

Total votes: 0
BrainStorm gets FDA fast-track status for ALS stem cell therapy
Israel's BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration has designated its adult stem cell treatment as a "fast-track" product for the treatment of amyotrophic lateral sclerosis (ALS).
Source: Reuters
Posted on: Tuesday, Oct 07, 2014, 8:15am
Views: 1197
Comments
No comments recorded.
Add Comment?
Comments are closed 2 weeks after initial post.
Friends